Levomefolate calcium
左甲柳叶酸钙
Report date: 2026/05/26 20:00:28
NME
Base Information
Drug NameLevomefolate calcium
Drug Alias Name +[12]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2011/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMerck & Co Inc
China Registration ClassN/A
Develop Information
Active CompaniesCox BiosciencesMerck LtdBei Jing Scrianen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A